Skip to main content

Emerging Technologies

By HIMSS TV | 05:59 pm | November 13, 2020
Pothik Chatterjee, executive director of innovation and research at LifeBridge Health, says his team responded to the COVID-19 crisis with mobile clinics, digital patient monitoring and on-site PPE production.
By Sara Mageit | 10:02 am | November 13, 2020
The tool, developed by UK fertility company Apricity, converts information on age, BMI, alcohol and smoking to predict fertility among women. 
By Laura Lovett | 04:11 pm | November 12, 2020
LifeBridge Health's executive director of innovation and research, Pothik Chatterjee, talks about the health system's efforts ahead of Accelerate Health's second episode. 
By HIMSS TV | 09:20 am | November 12, 2020
George Halvorson, chair and CEO of the Institute for InterGroup Understanding, explains why it's imperative to collect and share data to focus on disparities in care.
By Dean Koh | 03:33 am | November 10, 2020
Named Hospitech AwakeZone Medical, the JV will develop the production capabilities of Hospitech Respiration’s AnapnoGuard device in China and lead the commercialization of the device in the greater China market.
By Sophie Porter | 02:55 am | November 10, 2020
The smartphone blood testing service is one of just a handful of SMEs selected for annual programme to transform the NHS.
By Ian Chiang and Poorwa Godbole | 12:03 pm | November 06, 2020
Flare Capital's Ian Chiang and Poorwa Godbole highlight the healthcare changes COVID-19 has already spurred and discuss why they're likely to stick around for the long haul.
By Dave Muoio | 03:06 pm | November 04, 2020
The tool was "100% accurate" when spotting cases among asymptomatic individuals, the researchers wrote, and could be deployed as a low-cost prescreener to support diagnostic testing efforts.
By Sara Mageit | 12:44 pm | November 04, 2020
The launch coincides with 54gene being appointed as a country partner in a global registry study of healthcare workers exposed to COVID-19.
By Laura Lovett | 03:54 pm | November 03, 2020
The company is releasing its research on mapping biomarkers for depression.